Cellfe Inc.
Publicly observedAtlanta, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Atlanta | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Cellfe Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | M34JNT47EKK3 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant18 Sept 2026Publicly observed
NIH SBIR/STTR award: High throughput, high efficiency, rapid mechanical transfection for CAR T-cell therapeutics
USD 1,052,108.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 Sept 2025Publicly observed
NIH SBIR/STTR award: Accelerated, scalable same-day microfluidic sequential gene editing for allogeneic cell therapy
USD 314,000.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.